RLAY - Relay Therapeutics Inc
IEX Last Trade
6.8
0.040 0.588%
Share volume: 1,166,761
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.76
0.04
0.59%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-02-23 | 2023-05-04 | 2023-08-08 | 2023-11-02 | 2024-02-22 | 2024-05-02 | |
| Assets | |||||||||
| Total Assets | 889.421 M | 1.169 B | 1.100 B | 1.038 B | 962.016 M | 906.959 M | 843.980 M | 841.441 M | |
| Current Assets | 855.793 M | 1.087 B | 1.020 B | 958.388 M | 884.349 M | 831.798 M | 770.103 M | 770.100 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 17.515 M | 33.264 M | 20.282 M | 20.298 M | 12.698 M | 20.972 M | 20.017 M | 20.492 M | |
| Short Term Investments | 17.515 M | 33.264 M | 20.282 M | 20.298 M | 12.698 M | 20.972 M | 20.017 M | 20.492 M | |
| Total Receivables | 288.000 K | 241.000 K | 306.000 K | 286.000 K | 78.000 K | 211.000 K | 0.000 | 0.000 | |
| Current Cash | 837.990 M | 1.054 B | 998.917 M | 937.804 M | 871.573 M | 810.615 M | 750.086 M | 749.608 M | |
| Total Non-current Assets | 33.628 M | 81.421 M | 80.266 M | 79.172 M | 77.667 M | 75.161 M | 73.877 M | 71.341 M | |
| Property Plant Equipment | 8.922 M | 11.390 M | 11.634 M | 11.950 M | 11.749 M | 10.701 M | 10.901 M | 9.875 M | |
| Other Assets | 19.828 M | 65.153 M | 63.754 M | 62.344 M | 60.911 M | 59.453 M | 57.969 M | 56.459 M | |
| Intangible Assets | 2.300 M | 2.300 M | 2.300 M | 2.300 M | 2.300 M | 2.300 M | 2.300 M | 2.300 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 889.421 M | 1.169 B | 1.100 B | 1.038 B | 962.016 M | 906.959 M | 843.980 M | 841.441 M | |
| Total liabilities | 109.784 M | 168.949 M | 149.553 M | 154.148 M | 151.897 M | 128.586 M | 91.977 M | 95.677 M | |
| Total current liabilities | 43.902 M | 71.427 M | 63.709 M | 70.467 M | 71.576 M | 50.748 M | 30.269 M | 37.144 M | |
| Accounts Payable | 4.296 M | 9.485 M | 10.578 M | 11.834 M | 14.778 M | 13.353 M | 9.211 M | 7.973 M | |
| Other liabilities | 45.863 M | 42.922 M | 32.378 M | 31.375 M | 29.223 M | 28.023 M | 13.206 M | 11.374 M | |
| Current long term debt | 2.002 M | 5.681 M | 4.276 M | 4.441 M | 4.610 M | 4.785 M | 4.964 M | 5.147 M | |
| Long term debt | 20.019 M | 54.600 M | 53.466 M | 52.306 M | 51.098 M | 49.815 M | 48.502 M | 47.159 M | |
| Other liabilities | 45.863 M | 42.922 M | 32.378 M | 31.375 M | 29.223 M | 28.023 M | 13.206 M | 11.374 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 779.637 M | 999.769 M | 950.218 M | 883.412 M | 810.119 M | 778.373 M | 752.003 M | 745.764 M | |
| Common stock | 108.644 M | 110.906 M | 121.091 M | 121.321 M | 121.681 M | 122.231 M | 125.073 M | 130.843 M | |
| Retained earnings | -906.934 M | -991.106 M | -1.059 B | -1.153 B | -1.251 B | -1.317 B | -1.401 B | -1.482 B |